Keyphrases
Fibrosis
100%
Antifibrotic
100%
Transcription Factor
100%
Early Growth Response Protein 1 (EGR1)
100%
Human Disease
20%
Transforming Growth Factor-β
20%
Aging
10%
Phosphorylation
10%
Gene Expression
10%
In Cancer
10%
Scleroderma
10%
Fibrotic Response
10%
Profibrotic
10%
Clinical Efficacy
10%
Idiopathic Pulmonary Fibrosis
10%
Tissue Repair
10%
NF-B
10%
Multiple Cell Types
10%
Post-translational Modification
10%
Nuclear Translocation
10%
Physiologic
10%
Response to Stress
10%
Biological Response
10%
Null Mice
10%
Response to Injury
10%
Extracellular Signaling
10%
Cellular Environment
10%
Acute Changes
10%
Inflammation Injury
10%
Ischemic Injury
10%
Cancer-related Inflammation
10%
Smad2
10%
C-Jun
10%
Ligand-activated Transcription Factors
10%
Connective Tissue Remodeling
10%
Human Obesity
10%
Immediate-early Response
10%
Medicine and Dentistry
Mediator
100%
Fibrosis
100%
Early Growth Response Factor
100%
Diseases
28%
Cancer Growth Factor
28%
Prevalence
14%
Connective Tissue
14%
Gene Expression
14%
Ischemic Injury
14%
Protein Processing
14%
Malignant Neoplasm
14%
Idiopathic Pulmonary Fibrosis
14%
Injury
14%
Tissue Repair
14%
Transcription Factor Egr 1
14%
Atherosclerosis
14%
Transcription Factors
14%
Scleroderma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Early Growth Response Factor
100%
Fibrosis
100%
Injury
28%
Cancer Growth Factor
28%
Disease
28%
Knockout Mouse
14%
Malignant Neoplasm
14%
Prevalence
14%
Atherosclerosis
14%
Fibrosing Alveolitis
14%
Tissue Repair
14%
Transcription Factor Egr 1
14%
Scleroderma
14%
Inflammation
14%
Transcription Factors
14%